A detailed history of Howard Financial Services, Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Howard Financial Services, Ltd. holds 3,333 shares of ABBV stock, worth $656,001. This represents 0.09% of its overall portfolio holdings.

Number of Shares
3,333
Previous 3,299 1.03%
Holding current value
$656,001
Previous $600,000 4.83%
% of portfolio
0.09%
Previous 0.1%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$154.79 - $180.76 $5,262 - $6,145
34 Added 1.03%
3,333 $571,000
Q1 2024

Apr 16, 2024

SELL
$159.82 - $182.1 $80,709 - $91,960
-505 Reduced 13.28%
3,299 $600,000
Q4 2023

Jan 09, 2024

BUY
$137.6 - $154.97 $25,318 - $28,514
184 Added 5.08%
3,804 $589,000
Q3 2023

Oct 10, 2023

BUY
$133.59 - $154.65 $39,275 - $45,467
294 Added 8.84%
3,620 $539,000
Q2 2023

Jul 12, 2023

SELL
$132.51 - $164.9 $2,252 - $2,803
-17 Reduced 0.51%
3,326 $448,000
Q1 2023

Apr 05, 2023

BUY
$144.61 - $166.54 $29,211 - $33,641
202 Added 6.43%
3,343 $532,000
Q4 2022

Jan 13, 2023

BUY
$138.31 - $165.87 $140,246 - $168,192
1,014 Added 47.67%
3,141 $0
Q3 2022

Oct 12, 2022

BUY
$134.21 - $153.93 $42,141 - $48,334
314 Added 17.32%
2,127 $285,000
Q2 2022

Jul 18, 2022

BUY
$137.62 - $174.96 $51,057 - $64,910
371 Added 25.73%
1,813 $278,000
Q1 2022

Apr 20, 2022

SELL
$131.98 - $163.75 $217,766 - $270,187
-1,650 Reduced 53.36%
1,442 $234,000
Q4 2021

Jan 27, 2022

BUY
$107.43 - $135.93 $45,442 - $57,498
423 Added 15.85%
3,092 $419,000
Q3 2021

Nov 01, 2021

SELL
$106.4 - $120.78 $157,365 - $178,633
-1,479 Reduced 35.66%
2,669 $288,000
Q2 2021

Aug 06, 2021

BUY
$105.21 - $117.21 $79,117 - $88,141
752 Added 22.14%
4,148 $467,000
Q1 2021

May 03, 2021

BUY
$102.3 - $112.62 $9,309 - $10,248
91 Added 2.75%
3,396 $368,000
Q4 2020

Feb 02, 2021

BUY
$80.49 - $108.67 $266,019 - $359,154
3,305 New
3,305 $354,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $348B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Howard Financial Services, Ltd. Portfolio

Follow Howard Financial Services, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howard Financial Services, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Howard Financial Services, Ltd. with notifications on news.